Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577683![]() (US11478451, Example 087 | US11478451, Example 088 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577720![]() ((rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577692![]() (US11478451, Example 096 | US11478451, Example 097 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572210![]() ((9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571489![]() ((+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572210![]() ((9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577692![]() (US11478451, Example 096 | US11478451, Example 097 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572180![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577683![]() (US11478451, Example 087 | US11478451, Example 088 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571480![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572202![]() ((rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577664![]() ((rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572210![]() ((9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577689![]() (US11478451, Example 093) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571527![]() ((rac)-(rac-15)-benzyl-4-chloro-3-ethyl-7-{3-[(6-fl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.32E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571510![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571472![]() ((−)-4-chloro-15-cyclopropyl-2,3-dimethyl-7-{...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.38E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577686![]() (US11478451, Example 090 | US11478451, Example 091 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577698![]() ((rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572205![]() ((rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571465![]() ((+)-4-chloro-15-ethyl-2,3-dimethyl-7-{3-[(naphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.42E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571490![]() ((−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.43E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571488![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.47E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571478![]() ((+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572210![]() ((9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572166![]() ((rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577701![]() ((rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571477![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577664![]() ((rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571496![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.54E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572205![]() ((rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577706![]() ((+)-4′-chloro-3′-ethyl-7′-{3-[(6...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572149![]() (US11447504, Example 2 | US11447504, Example 3 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577705![]() ((−)-4′-chloro-3′-ethyl-7′-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577700![]() ((−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphtha...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572212![]() ((9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572183![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571473![]() ((rac)-4-chloro-(15-rac)-(2-methoxyethyl)-2,3-dimet...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.71E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571479![]() ((−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthal...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.72E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572180![]() ((rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577683![]() (US11478451, Example 087 | US11478451, Example 088 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572212![]() ((9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571475![]() ((+)-4-chloro-15-cyclopropyl-3-ethyl-7-{3-[(6-fluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.81E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM577659![]() ((rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572212![]() ((9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM572205![]() ((rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2NG4TXW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide (Homo sapiens (Human)) | BDBM571464![]() ((rac)-4-Chloro-15-cyclopropyl-2,3-dimethyl-7-{3-[(...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.98E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The dose-dependent inhibition by the compounds described in this invention of the interaction between BCL-XL and the BH3 domain of Bad (both human) w... | Citation and Details BindingDB Entry DOI: 10.7270/Q2J38WT5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212] (Homo sapiens (Human)) | BDBM544459![]() ((rac)-(11Z)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description BCL-XL Assay: In the assay 11 different concentrations of each compound (0.1 nM, 0.33 nM, 1.1 nM, 3.8 nM, 13 nM, 44 nM, 0.15 μM, 0.51 μM, 1... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MWD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212] (Homo sapiens (Human)) | BDBM544460![]() ((rac)-4-fluoro-2,3-dimethyl-7-[3-(naphthalen-1-ylo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description BCL-XL Assay: In the assay 11 different concentrations of each compound (0.1 nM, 0.33 nM, 1.1 nM, 3.8 nM, 13 nM, 44 nM, 0.15 μM, 0.51 μM, 1... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MWD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 [1-212] (Homo sapiens (Human)) | BDBM544464![]() ((rac)-(11Z)-3-ethyl-4-fluoro-2-methyl-7-[3-(naphth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description BCL-XL Assay: In the assay 11 different concentrations of each compound (0.1 nM, 0.33 nM, 1.1 nM, 3.8 nM, 13 nM, 44 nM, 0.15 μM, 0.51 μM, 1... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MWD | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 254 total ) | Next | Last >> |